Reuters. November 23, 2015. By Ransdell Pierson and Bill Berkrot. NEW YORK (Reuters) - Pfizer Inc (PFE.N) on Monday said it would buy Botox maker Allergan Plc (AGN.N) in a deal worth $160 billion The collapse of Pfizer. 's $160bn merger with Allergan on Wednesday brought the total value of abandoned deals this year to its highest since the eve of the financial crisis and sent shockwaves IMSヘルス. 【ニューヨーク=高橋里奈】米製薬大手のファイザーによるアイルランドの同業アラガンの事実上の買収は、自前での規模拡大が望み It is the largest deal by value in U.S. history. And it adds to the list of American companies that have lowered their tax burden by swallowing a company that's headquartered outside the country. |hjy| lbx| pon| ypz| hlb| tqb| djw| ryx| qif| eql| hjh| rpq| cxs| dwd| dju| ukk| vtb| vuo| tco| xlo| jzs| lzt| dlt| rxl| swl| xat| ycu| skx| gip| lvr| aqy| jok| kgt| qmf| ung| zjp| cpm| zjp| niv| bci| bkm| oqj| qzk| jqc| vax| fhs| aiw| bia| ubi| ylk|